+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antiplatelet Drugs"

Anti-Platelet Agents - Global Strategic Business Report - Product Thumbnail Image

Anti-Platelet Agents - Global Strategic Business Report

  • Report
  • March 2025
  • 94 Pages
  • Global
From
From
From
From
Thrombosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Thrombosis Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 387 Pages
  • Global
From
Cardiovascular Drugs - Global Strategic Business Report - Product Thumbnail Image

Cardiovascular Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 413 Pages
  • Global
From
Ischemic Heart Disease (IHD) Drugs Market Report 2025 - Product Thumbnail Image

Ischemic Heart Disease (IHD) Drugs Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Atherosclerosis Drugs Market Report 2025 - Product Thumbnail Image

Atherosclerosis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Acute Ischemic Stroke Drugs Market Report 2025 - Product Thumbnail Image

Acute Ischemic Stroke Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Critical Limb Ischemia Market Report 2025 - Product Thumbnail Image

Critical Limb Ischemia Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024 - Product Thumbnail Image

Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
Ischemic Stroke Market Report and Forecast 2024-2032 - Product Thumbnail Image

Ischemic Stroke Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
Loading Indicator

The Antiplatelet Drugs market within the context of Cardiovascular Drugs is a rapidly growing sector of the pharmaceutical industry. Antiplatelet drugs are used to reduce the risk of heart attack and stroke by preventing the formation of blood clots. These drugs are used to treat a variety of cardiovascular conditions, including coronary artery disease, peripheral artery disease, and atrial fibrillation. Commonly prescribed antiplatelet drugs include aspirin, clopidogrel, ticagrelor, and prasugrel. These drugs are typically taken orally, and are often prescribed in combination with other medications. In addition to reducing the risk of heart attack and stroke, antiplatelet drugs can also reduce the risk of other cardiovascular complications, such as deep vein thrombosis and pulmonary embolism. Some of the major companies in the Antiplatelet Drugs market include Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more